Join us for our last Training Program of the year, as we explore pragmatic clinical trials in Alberta.

The Patient-Oriented Research Training Program provides participants with a foundational understanding of Patient-Oriented Research (POR). It is intended to help equip research team members with the skills and knowledge necessary to engage meaningfully in projects that involve a POR approach.

The Training Program is open to anyone who is collaborating, or planning to collaborate, in POR. It is intended for graduate students, trainees, community and academic researchers, patients and family members, health care professionals, decision-makers, and industry and community stakeholders who are interested in learning about, or contributing to, POR in Alberta.

Register here: https://goo.gl/MC8Rsm

Session 8: Clinical Trials in Alberta

As always this is a free, introductory session with leaders in Patient Oriented Research.

The session will take place in Calgary (Theatre 1, HSC), with broadcasts in Edmonton (ECHA 4-001), and Lethbridge (TH241), and online.

Engaging patients in Setting Research Priorities, and Working Within Research Projects: Implementing and Evaluating (PROMs) Patient-Reported Outcomes Measures in Hemodialysis Across Alberta

With Speaker Dr. Braden Manns

Braden Manns is the Svare Professor in Health Economics and a Nephrologist at the University of Calgary in the Departments of Medicine and Community Health Sciences and an Alberta Innovates – Health Solutions Health Scholar. The mission of the Svare Chair is to develop a world-class Health Economics research and academic program that focuses on evaluating the clinical and economic impact of health care technologies and health care policies of relevance to health care policy makers. He has expertise in Applied Health Economics and clinical research in Nephrology and is co-PI for an inter-disciplinary team grant investigating chronic disease (www.icdc.ca/).

Dr. Manns current research interests include examining the implications of patient-borne costs on care and outcomes in chronic disease, examining the cost effectiveness of strategies and health care policies for managing patients with chronic disease, and assessing the adequacy of care for Albertans with diabetes, among other projects. He has experience in pharmaceutical priority setting, having served on provincial and national committees for drug evaluation, including a term as Chair of Canadian Expert Drug Advisory Committee from 2006-2008. Dr. Manns is the President of the Canadian Society of Nephrology and principal investigator of a Canadian kidney disease knowledge translation network, guiding health policy for patients with kidney disease (www.CANN-NET.ca). Dr. Manns teaches a graduate course in economic evaluation and supervises graduate students at all levels of training

If you have any questions, please forward them on to matthew.mancuso@ucalgary.ca